Life Sciences Tools & Services Companies By Net Asset

Net Asset
Net AssetEfficiencyMarket RiskExp Return
1TMO Thermo Fisher Scientific
98.73 B
(0.17)
 1.24 
(0.21)
2IQV IQVIA Holdings
26.68 B
(0.17)
 1.86 
(0.32)
3ICLR ICON PLC
16.99 B
(0.16)
 3.45 
(0.56)
4RVTY Revvity
13.56 B
(0.02)
 1.64 
(0.03)
5AVTR Avantor
12.97 B
(0.18)
 1.47 
(0.27)
6BIO Bio Rad Laboratories
12.3 B
 0.02 
 2.33 
 0.06 
7A Agilent Technologies
10.76 B
 0.00 
 1.63 
 0.00 
8ILMN Illumina
10.11 B
 0.08 
 2.30 
 0.19 
9CRL Charles River Laboratories
8.2 B
 0.03 
 2.58 
 0.09 
10QGEN Qiagen NV
6.12 B
(0.02)
 1.26 
(0.02)
11WAT Waters
4.63 B
 0.08 
 2.95 
 0.24 
12FTRE Fortrea Holdings
4.36 B
 0.01 
 5.05 
 0.03 
13BRKR Bruker
4.25 B
(0.06)
 2.68 
(0.16)
14MTD Mettler Toledo International
3.36 B
(0.08)
 1.95 
(0.16)
15SHC Sotera Health Co
3.13 B
(0.09)
 2.46 
(0.21)
16RGEN Repligen
2.82 B
 0.05 
 3.10 
 0.14 
17TECH Bio Techne Corp
2.7 B
 0.05 
 2.35 
 0.11 
18AZTA Azenta Inc
2.1 B
(0.01)
 2.60 
(0.02)
19PACB Pacific Biosciences of
1.75 B
 0.12 
 6.73 
 0.78 
20NEO NeoGenomics
1.68 B
 0.08 
 2.66 
 0.21 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund. Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.